MedPath

Berlin Cures GmbH

Berlin Cures GmbH logo
🇩🇪Germany
Ownership
Holding
Established
2014-01-01
Employees
11
Market Cap
-
Website
http://berlincures.de

Clinical Trials

7

Active:4
Completed:3

Trial Phases

2 Phases

Phase 1:5
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 1
5 (71.4%)
Phase 2
2 (28.6%)

To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID

Phase 2
Completed
Conditions
Long Covid
Interventions
Drug: BC 007 or matching placebo
First Posted Date
2023-06-20
Last Posted Date
2024-11-18
Lead Sponsor
Berlin Cures GmbH
Target Recruit Count
119
Registration Number
NCT05911009
Locations
🇦🇹

Klinik Favoriten - Wiener Gesundheitsverbund, Vienna, Austria

🇦🇹

Klinik Floridsdorf - Wiener Gesundheitsverbund, Vienna, Austria

🇫🇮

Terveystalo Helsinki Sleep Clinic, Helsinki, Nyland And Tavastehus County, Finland

and more 13 locations

The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor

Phase 2
Completed
Conditions
Cardiomyopathy, Dilated
Autoantibodies
Heart Failure
Interventions
First Posted Date
2019-12-10
Last Posted Date
2023-04-03
Lead Sponsor
Berlin Cures GmbH
Target Recruit Count
30
Registration Number
NCT04192214
Locations
🇷🇸

Institut za kardiovaskularne bolesti Dedinje, Belgrade, Serbia

🇷🇸

Zvezdara Clinical and Hospital Centre, Belgrade, Serbia

🇷🇸

Bežanijska Kosa Clinical and Hospital Centre, Belgrad, Serbia

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of BC 007 in Healthy Subjects

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: NaCl 0.9 %
First Posted Date
2016-11-04
Last Posted Date
2018-07-18
Lead Sponsor
Berlin Cures GmbH
Target Recruit Count
74
Registration Number
NCT02955420
Locations
🇩🇪

PAREXEL International GmbH, Early Phase Clinical Unit Berlin, Berlin, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.